|
1
|
Bae KT: Intravenous contrast medium
administration and scan timing at CT: Considerations and
approaches. Radiology. 256:32–61. 2010.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Bottinor W, Polkampally P and Jovin I:
Adverse reactions to iodinated contrast media. Int J Angiol.
22:149–154. 2013.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Zhang B, Dong Y, Liang L, Lian Z, Liu J,
Luo X, Chen W, Li X, Liang C and Zhang S: The incidence,
classification, and management of acute adverse reactions to the
low-osmolar iodinated contrast media isovue and ultravist in
contrast-enhanced computed tomography scanning. Medicine
(Baltimore). 95(e3170)2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Bannon GA: Hypersensitivity: Anaphylactic
(Type I). In Van Nostrand's Scientific Encyclopedia. G.D. Considine
(ed.). Wiley & Sons, Inc., Hoboken NJ, 2007. https://doi.org/10.1002/9780471743989.vse9966.
|
|
5
|
Nakamura T: The roles of lipid mediators
in type I hypersensitivity. J Pharmacol Sci. 147:126–131.
2021.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Nagata Y and Suzuki R: FcεRI: A master
regulator of mast cell functions. Cells. 11(622)2022.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Kanagaratham C, El Ansari YS, Lewis OL and
Oettgen HC: IgE and IgG antibodies as regulators of mast cell and
basophil functions in food allergy. Front Immunol.
11(603050)2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Gilfillan AM and Rivera J: The tyrosine
kinase network regulating mast cell activation. Immunol Rev.
228:149–169. 2009.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Shefler I, Salamon P and Mekori YA:
MicroRNA involvement in allergic and non-allergic mast cell
activation. Int J Mol Sci. 20(2145)2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Bao Y, Wang S, Gao Y, Zhang W, Jin H, Yang
Y and Li J: MicroRNA-126 accelerates IgE-mediated mast cell
degranulation associated with the PI3K/Akt signaling pathway by
promoting Ca(2+) influx. Exp Ther Med. 16:2763–2769.
2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Xiao L, Jiang L, Hu Q and Li Y: MiR-302e
attenuates allergic inflammation in vitro model by targeting RelA.
Biosci Rep. 38:2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Griffiths-Jones S: miRBase: The microRNA
sequence database. Methods Mol Biol. 342:129–138. 2006.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Langmead B and Salzberg SL: Fast
gapped-read alignment with Bowtie 2. Nat Methods. 9:357–359.
2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Li H, Handsaker B, Wysoker A, Fennell T,
Ruan J, Homer N, Marth G, Abecasis G and Durbin R: 1000 Genome
Project Data Processing Subgroup. The Sequence Alignment/Map format
and SAMtools. Bioinformatics. 25:2078–2079. 2009.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Robinson MD, McCarthy DJ and Smyth GK:
edgeR: A Bioconductor package for differential expression analysis
of digital gene expression data. Bioinformatics. 26:139–140.
2010.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Wang L, Feng Z, Wang X, Wang X and Zhang
X: DEGseq: An R package for identifying differentially expressed
genes from RNA-seq data. Bioinformatics. 26:136–138.
2010.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Enright AJ, John B, Gaul U, Tuschl T,
Sander C and Marks DS: MicroRNA targets in Drosophila. Genome Biol.
5(R1)2003.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Agarwal V, Bell GW, Nam JW and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
Elife. 4(e05005)2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Kertesz M, Iovino N, Unnerstall U, Gaul U
and Segal E: The role of site accessibility in microRNA target
recognition. Nat Genet. 39:1278–1284. 2007.PubMed/NCBI View
Article : Google Scholar
|
|
20
|
Yu G, Wang LG, Han Y and He QY:
ClusterProfiler: An R package for comparing biological themes among
gene clusters. OMICS. 16:284–287. 2012.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Luo W, Pant G, Bhavnasi YK, Blanchard Jr
SG and Brouwer C: Pathview Web: User friendly pathway visualization
and data integration. Nucleic Acids Res. 45(W1):W501–W508.
2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Chang L, Zhou G, Soufan O and Xia J:
miRNet 2.0: Network-based visual analytics for miRNA functional
analysis and systems biology. Nucleic Acids Res. 48(W1):W244–W251.
2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Gil-Martínez M, Lorente-Sorolla C, Naharro
S, Rodrigo-Muñoz JM and del Pozo V: Advances and Highlights of
miRNAs in Asthma: Biomarkers for diagnosis and treatment. Int J Mol
Sci. 24(1628)2023.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Kulkarni KN, Hegde RG, Balani A and Joshi
AR: Transient angioedema of small bowel secondary to intravenous
iodinated contrast medium. Indian J Radiol Imaging. 24:303–305.
2014.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Zou W, Yang S, Chen L, Hu S, Hao G and Hu
C: Iodixanol activation of mast cells: Implications in the
pathogenesis of iodixanol-induced delayed cutaneous adverse
reactions. Toxicology. 465(153034)2022.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Lee SH, Park JW and Hwang BM: Anaphylactic
shock following nonionic contrast medium during caudal epidural
injection. Korean J Pain. 28:280–283. 2015.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Li Y, Liu J, Zhang J, Zhang W and Wu Z:
Characterization of microRNA profile in IgE-mediated mouse BMMCs
degranulation. J Microbiol Immunol Infect. 53:550–560.
2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Teng Y, Zhang R, Yu H, Wang H, Hong Z,
Zhuang W and Huang Y: Altered MicroRNA expression profiles in
activated mast cells following IgE-FcεRI cross-linking with
antigen. Cell Physiol Biochem. 35:2098–2110. 2015.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Zhu X, Guo Q, Zou J, Wang B, Zhang Z, Wei
R, Zhao L, Zhang Y, Chu C, Fu X and Li X: MiR-19a-3p Suppresses M1
macrophage polarization by inhibiting STAT1/IRF1 pathway. Front
Pharmacol. 12(614044)2021.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Xu G, Li J and Yu L: miR-19a-3p promotes
tumor-relevant behaviors in bladder urothelial carcinoma via
targeting THBS1. Comput Math Methods Med.
2021(2710231)2021.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Jiang L, Wang M, Sun R, Lin Z, Liu R, Cai
H, Tang Z and Zhang R: Methylation of miR-19b-3p promoter
exacerbates inflammatory responses in sepsis-induced ALI via
targeting KLF7. Cell Biol Int. 45:1666–1675. 2021.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Ye L, Morse LR, Falci SP, Olson JK,
Shrivastava M, Nguyen N, Linnman C, Troy KL and Battaglino RA:
hsa-MiR-19a-3p and hsa-MiR-19b-3p Are Associated with Spinal Cord
Injury-Induced Neuropathic Pain: Findings from a Genome-Wide
MicroRNA Expression Profiling Screen. Neurotrauma Rep. 2:424–439.
2021.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Wang D, Wang H, Li Y and Li Q: MiR-362-3p
functions as a tumor suppressor through targeting MCM5 in cervical
adenocarcinoma. Biosci Rep. 38(BSR20180668)2018.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Cao S, Li N and Liao X: miR-362-3p acts as
a tumor suppressor by targeting SERBP1 in ovarian cancer. J Ovarian
Res. 14(23)2021.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Wang X and Chen P: Aberrant miR-362-3p is
Associated with EBV-Infection and prognosis in nasopharyngeal
carcinoma and involved in tumor progression by targeting JMJD2A.
Onco Targets Ther. 15:121–131. 2022.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Omidbakhsh A, Saeedi M, Khoshnia M,
Marjani A and Hakimi S: Micro-RNAs-106a and -362-3p in peripheral
blood of inflammatory bowel disease patients. Open Biochem J.
12:78–86. 2018.PubMed/NCBI View Article : Google Scholar
|
